Panacea Biotec Ltd.
https://www.panacea-biotec.com/
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Panacea Biotec Ltd.
J&J, Pfizer, Russian COVID-19 Vaccines Set For Indian Approval In '21
Multiple COVID-19 vaccines, including from J&J, Pfizer and RDIF, are seen gaining approvals in India in 2021, following on from a raft of R&D, manufacturing and marketing tie-ups, as well as other developments, in the action-packed field last year.
India-China Tango: Can Gland Sustain Listing Luster?
Gland Pharma, controlled by Chinese group Fosun, makes shining debut on Indian stock markets despite a lukewarm response to its IPO. Will the buoyant market sentiment sustain amid edgy India-China relations?
Panacea Biotec Hit By FDA Warning Letter
After receiving a response from Panacea Biotec in March 2020 over Form 483 observations stemming from a February inspection, the FDA has gone ahead and issued a warning letter to the company relating to its manufacturing facility based in Himachal Pradesh, India, citing two key cGMP violations.
Coronavirus Update: Moderna In Advanced Talks With Europe On Vaccine Supplies
The deal would include an option for expansion to 160 million doses of the mRNA-based vaccine.
Company Information
- Industry
- Biotechnology
- Contract Research, Toxicology Testing-CRO
- Distributors
- Pharmaceuticals
-
Pharmaceuticals
- Drug Delivery
- OTC, Consumer
- Vaccines